• Publications
  • Influence
Readmissions after implantation of axial flow left ventricular assist device.
Echocardiographic Variables After Left Ventricular Assist Device Implantation Associated With Adverse Outcome
Mortality and heart failure after LVAD surgery appear to be predominantly determined by echocardiographic evidence of inefficient unloading of the left ventricle and persistence of right ventricular dysfunction.
Changes in renal function after implantation of continuous-flow left ventricular assist devices.
Sirolimus as Primary Immunosuppression Attenuates Allograft Vasculopathy With Improved Late Survival and Decreased Cardiac Events After Cardiac Transplantation
Background— We retrospectively analyzed the potential of sirolimus as a primary immunosuppressant in the long-term attenuation of cardiac allograft vasculopathy progression and the effects on
Low-dose nesiritide in human anterior myocardial infarction suppresses aldosterone and preserves ventricular function and structure: a proof of concept study
72 h infusion of low BNP at the time of anterior AMI is well tolerated and biologically active and patients treated with low-dose BNP had improved LVEF and smaller LV end-systolic volume at 1 month.
Equimolar doses of atrial and brain natriuretic peptides and urodilatin have differential renal actions in overt experimental heart failure.
Cardiorenal and humoral actions of 90 min of intravenous equimolar infusion of ANP, BNP, and Uro support the conclusion that in experimental overt CHF, renal resistance to natriuretic peptides in increasing rank order is BNP.
Current Status of Left Ventricular Assist Device Therapy.